也有人看好

"

$30 billion
 
Last night, the Wall Street Journal reported that the pharma company is in very early talks to acquire Seagen Inc. for more than $30 billion, a deal that would instantly add four approved cancer drugs to its portfolio.4 hours ago
请您先登陆,再发跟帖!